Preconditioning with monophosphoryl lipid A improves survival of critically ischemic tissue

Anesthesia and Analgesia

Volumn 100, Issue 6, 2005, Pages 1786-1792

  Harder, Yves ^a   Contaldo, Claudio ^a   Klenk, Joachim ^a   Banic, Andrej ^a   Jakob, Stephan M ^a   Erni, Dominique ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; FOREN; ISOFLURANE; KETAMINE; MIDAZOLAM; MIDAZOLAM MALEATE; NARKETAN; NITROUS OXIDE PLUS OXYGEN; PHOSPHORYL LIPID A; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BUTTOCK; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; CRITICAL ILLNESS; HEART INDEX; HEMODYNAMICS; ISCHEMIA; LASER DOPPLER FLOWMETRY; MICROCIRCULATION; NONHUMAN; OXYGEN SUPPLY; OXYGEN TISSUE LEVEL; OXYGENATION; POLAROGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL; SWINE; SYSTEMIC VASCULAR RESISTANCE; TISSUE FLAP; TISSUE NECROSIS; TISSUE PERFUSION; WOUND; WOUND HEALING;

ANESTHESIA, GENERAL; ANIMALS; BLOOD GAS ANALYSIS; HEMODYNAMIC PROCESSES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LASER-DOPPLER FLOWMETRY; LIPID A; MYOCARDIAL ISCHEMIA; MYOCARDIUM; SURGICAL FLAPS; SWINE;

EID: 19044362044     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000152007.14854.6B     Document Type: Article

References (25)

1. Hosnuter M, Babuccu O, Kargi E, Altinyazar C. Dual preconditioning: effects of pharmacological plus ischemc preconditioning on skin flap survival. Ann Plast Surg 2003;50:398-402.
2. Matsumura H, Yoshizawa N, Vedder NB, Watanabe K. Preconditioning of the distal portion of a rat random-pattern skin flap. Br J Plast Surg 2001;54:58-61.
3. Bolli R. The late phase of preconditioning. Circ Res 2000;87:972-83.
4. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993;72:1293-9.
5. Qureshi N, Takayama K, Ribi E. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J Biol Chem 1982;257:11808-15.
6. Ulrich JT, Myers KR. Monophosphoryl lipid A as an adjuvant: past experiences and new directions. Pharm Biotechnol 1995;6:495-524.
7. Johnson AG, Tomai MA, Chen YF, Odean M. A comparison of the immunomodulating properties of two forms of monophosphoryl lipid A analogues. J Immunother 1991;10:398-404.
8. Astiz ME, Rackow EC, Still JG, et al. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med 1995;23:9-17.
9. Gustafson GL, Rhodes MJ, Hegel T. Monophosphoryl lipid A as a prophylactic for sepsis and septic shock. Prog Clin Biol Res 1995;392:567-79.
10. Maldonado C, Stadelmann WK, Ramirez S, et al. Preconditioning of latissimus dorsi muscle flaps with monophosphoryl lipid a. Plast Reconstr Surg 2003;111:267-74.
11. Richard V, Danielou E, Kaeffer N, Thuillez C. Delayed endothelial protective effects of monophosphoryl lipid A after myocardial ischemia and reperfusion in rats. J Mol Cell Cardiol 1999;31:1117-23.
12. Xi L, Jarrett NC, Hess ML, Kukreja RC. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation 1999;99:2157-63.
13. Zhao L, Weber PA, Smith JR, et al. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. J Mol Cell Cardiol 1997;29:1567-76.
14. Harder Y, Contaldo C, Klenk J, et al. Improved skin flap survival after local heat preconditioning in pigs. J Surg Res 2004;119:100-5.
15. Schramm S, Wettstein R, Wessendorf R, et al. Acute normovolemic hemodilution improves oxygenation in ischemic flap tissue. Anesthesiology 2002;96:1478-84.
16. Hickerson WL, Colgin SL, Proctor KG. Regional variations of laser Doppler blood flow in ischemic skin flaps. Plast Reconstr Surg 1990;86:319-26.
17. Harvey-Clark CJ, Gilespie K, Riggs KW. Transdermal fentanyl compared with parenteral buprenorphine in post-surgical pain in swine: a case study. Lab Anim 2000;34:386-98.
18. Carpati CM, Astiz ME, Rackow EC, et al. Monophosphoryl lipid A attenuates the effects of endotoxic shock in pigs. J Lab Clin Med 1992;119:346-53.
19. Astiz ME, Rackow EC, Kim YB, Weil MH. Monophosphoryl lipid A induces tolerance to the lethal hemodynamic effects of endotoxemia. Circ Shock 1991;33:92-7.
20. Gilbert M, Roberts SL, Mori M, et al. Comparative coronary vascular reactivity and hemodynamics during halothane and isoflurane anesthesia in swine. Anesthesiology 1988;68:243-53.
21. Weiskopf RB, Holmes MA, Rampil IJ, et al. Cardiovascular safety and actions of high concentrations of I-653 and isoflurane in swine. Anesthesiology 1989;70:793-8.
22. Przyklenk K, Hata K, Whittaker P, Elliott GT. Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis? J Cardiovasc Pharmacol 2000;35:366-75.
23. Kane AJ, Barker JE, Mitchell GM, et al. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival. Br J Pharmacol 2001;132:1631-8.
24. Ercocen AR, Apaydin I, Emiroglu M, et al. The effects of L-arginine and iloprost on the viability of random skin flaps in rats. Scand J Plast Reconstr Surg Hand Surg 1998;32:19-25.
25. Um SC, Suzuki S, Toyokuni S, et al. Involvement of nitric oxide in survival of random pattern skin flap. Plast Reconstr Surg 1998;101:785-92.